J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits

A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.